Bio-Techne
Bio-Techne Corp is an American life sciences developer and manufacturer providing biological reagents, diagnostic tools, and analytical instruments. The company operates through two main business segments: Protein Sciences and Diagnostics & Genomics. Its product portfolio includes recombinant proteins, antibodies, immunoassays, spatial biology tools, and automated protein analysis platforms under brands like R&D Systems and Novus Biologicals. Revenue is derived from the global sale of consumables, clinical reagents, diagnostic kits, and laboratory instrumentation to academic, pharmaceutical, and biotechnology research entities. Bio-Techne occupies a premier position in high-quality biological reagents and protein detection technologies globally. The company is headquartered in Minneapolis, Minnesota, United States, and its common stock is traded on the Nasdaq Global Select Market.
9 of the funds FundTelligence covers report a position in Bio-Techne.
- Legal name
- Bio-Techne Corp
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 9
Funds holding Bio-Techne
- Brown Advisory US Smaller Companies — Brown Advisory · 3.1 % (largest positions only, October 2026)
- Schroder ISF US Smaller Companies Impact — Schroders · 2.25 % (full portfolio disclosed, June 2026)
- SEB Nordamerikafond Små och Medelstora Bolag — SEB · 1.28 % (full portfolio disclosed, June 2026)
- BlackRock iShares Healthcare Innovation UCITS ETF — BlackRock · 1.11 % (full portfolio disclosed, October 2026)
- FTGF Royce US Smaller Companies Fund — Franklin Templeton · 0.81 % (full portfolio disclosed, September 2026)
- Schroder ISF Global Equity Impact — Schroders · 0.56 % (full portfolio disclosed, June 2026)
- DNB Global Enhanced Small Cap — DNB · 0.15 % (full portfolio disclosed, September 2026)
- Handelsbanken Global SMB Index Criteria — Handelsbanken · 0.12 % (full portfolio disclosed, October 2026)
Showing the 8 largest of 9 funds holding it.